Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-designed, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity

NCT06264453 is registered in ClinicalTrials.gov with HysensBio Co., Ltd as lead sponsor.

NCT NCT06264453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06264453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-designed, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity
Lead sponsor
HysensBio Co., Ltd
Phase
Phase 2
Overall status
Completed
Start date
March 19, 2024
Completion date
September 25, 2024
Enrollment
171 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dentin hypersensitivity